Ken Griffin Tiziana Life Sciences LTD Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 198,990 shares of TLSA stock, worth $443,747. This represents 0.0% of its overall portfolio holdings.
Number of Shares
198,990
Previous 24,000
729.13%
Holding current value
$443,747
Previous $25,000
1156.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TLSA
# of Institutions
33Shares Held
4.61MCall Options Held
0Put Options Held
0-
Dauntless Investment Group, LLC Commerce Township, MI3.42MShares$7.62 Million9.57% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$234,9630.0% of portfolio
-
Zhang Financial LLC89.8KShares$200,1640.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA86.1KShares$191,9690.0% of portfolio
-
Hrt Financial LP New York, NY84.1KShares$187,5560.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $228M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...